Valeant Announces 2017 Annual Meeting Results

May 03, 2017

LAVAL, QUEBEC, May 3, 2017 — Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) (“Valeant” or the “Company”) announced today the election of the ten directors nominated at its 2017 annual meeting of shareholders held on May 2, 2017. The detailed results of the vote for the election of directors are set out below:

Name

For

Withheld

Broker Non-Votes

 

 

 

 

Richard U. DeSchutter

123,623,109

5,319,736

98,872,954

Dr. Frederic N. Eshelman

126,125,069

2,817,776

98,872,954

D. Robert Hale

123,127,211

5,815,634

98,872,954

Dr. Argeris (Jerry) N. Karabelas

123,529,948

5,412,897

98,872,954

Sarah B. Kavanagh

126,292,442

2,650,403

98,872,954

Joseph C. Papa

123,983,101

4,959,744

98,872,954

Robert N. Power

125,649,938

3,292,907

98,872,954

Russel C. Robertson

126,590,227

2,352,618

98,872,954

Thomas W. Ross, Sr.

126,166,299

2,776,546

98,872,954

Amy B. Wechsler, M.D.

123,473,243

5,469,602

98,872,954

At the annual meeting, shareholders also approved the non-binding advisory vote on named executive officer compensation and an annual frequency of advisory votes on the compensation of our named executive as disclosed in the proxy statement and appointed PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm until the close of the Company's 2018 annual meeting of shareholders.

The final vote tabulation on all matters voted on at the meeting will be reported to the U.S. Securities and Exchange Commission on a current report on Form 8-K and such report will be made available on the Company's web site at www.valeant.com.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

Contact Information:

Elif McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)

Media:
Renée Soto
or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080